Observational studyWorld journal of gastroenterology2022

Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study.

Talat Bessissow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.